首页> 美国卫生研究院文献>Reports of Practical Oncology and Radiotherapy >Bone in the breast? Long term toxicity 21 years after interstitial brachytherapy as a boost
【2h】

Bone in the breast? Long term toxicity 21 years after interstitial brachytherapy as a boost

机译:骨头在乳房?间质近距离放射治疗21年后的长期毒性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An 81-year-old patient developed an exulcerous tumor in her left breast 21 years after breast cancer treatment with lumpectomy and adjuvant radiotherapy. At the time of the initial treatment 21 years ago, whole breast irradiation was performed with a prescribed dose of 48 Gy and a maximal dose of 69 Gy. In addition, the patient received a 14.7 Gy boost with multicatheter brachytherapy as partial breast irradiation.In general, fat necrosis after radiotherapy, surgery or trauma is a minor problem for patients, but can lead to diagnostic difficulties. The incidence varies: the literature indicates that it occurs in up to 34% of cases. The direct pathogenesis is not clear; it can be due to high radiation dose to the breast, dosimetric inhomogeneities or surgical complications (seromas and inflammation).The tumor in the case described here, occurring more than two decades after the primary treatment, is a rarity in this extent and is an unusual clinical, radiological, and histological finding. It provides a good example of the need for an individualized approach to treatment.
机译:一名81岁的患者在接受乳房切除术和辅助放疗的乳腺癌治疗21年后左乳房出现了溃疡性肿瘤。在21年前的初始治疗时,以48?Gy的处方剂量和69?Gy的最大剂量进行了全乳照射。此外,通过多导管近距离放射治疗作为部分乳房照射,患者接受了14.7μGy的增强治疗。一般而言,放射治疗,手术或外伤后的脂肪坏死对患者来说是一个小问题,但可能导致诊断困难。发病率各不相同:文献表明,高达34%的病例均会发生。直接发病机制尚不清楚;这可能是由于对乳房的高辐射剂量,剂量学上的不均匀性或外科手术并发症(血清肿和炎症)造成的。在此所述的情况下,在初次治疗后二十多年才发生的肿瘤在这种情况下是罕见的,并且是不寻常的临床,放射学和组织学发现。它提供了一个需要个体化治疗方法的好例子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号